Innovations in Peptide-based Nanomedicine
Immunova Biomed is a pioneering joint venture focused on peptide-based drugs and nanomedicine, addressing critical health challenges in cancer, immunologic diseases, and respiratory disorders through innovative biotechnology.
Welcome to ImmuNova BioMed
Founded in 2025, ImmuNova BioMed was established as a collaborative joint venture bringing together leading experts from the pharmaceutical industry and scientific research fields. Our mission is to become a global leader in the development of cutting-edge peptide-based drugs, innovative molecules for pharmacological and diagnostic applications, and advanced biotechnological solutions for nanomedicine. Our focus spans critical areas such as cancer, immunologic diseases, and respiratory disorders.
Our Expertise
At ImmuNova BioMed, we harness our extensive knowledge in encapsulation and controlled release of active compounds to revolutionize healthcare. Our innovative approach includes developing targeted nanoparticles designed for the precise delivery of drugs and imaging agents, significantly enhancing treatment safety and efficacy.
We strive to push the boundaries of biotechnology by providing transformative solutions across a wide range of biomedical disciplines, including Cancer, Neurology, Respiratory Diseases, Cardiovascular Biology and Oncology.
Our Vision
What We Do
As a pioneering biotech company, ImmuNova BioMed focuses on:
Synthetic RNA and Peptide Drug Discovery:
Developing groundbreaking peptide-based therapeutics.
Drug Delivery Systems
Creating nanoparticles for precise, targeted, and controlled drug release.
Innovating diagnostic methods to visualize and analyze pathological pathways.
Optical Imaging
At ImmuNova BioMed, we specialize in developing peptide-based drugs, RNA therapeutics, and nanoparticle delivery systems, with a focus on improving outcomes for patients with cancer, infectious diseases, and autoimmune disorders. Our solutions are designed to enhance precision, safety, and efficacy in treatment and diagnostics.
What Sets Us Apart
Innovation at the Core: We leverage cutting-edge technologies such as self-assembling nanovaccines, precision nanoparticles, and AI-driven treatment design to push the boundaries of biomedical science.
Patient-Centered Focus: Our solutions prioritize patient outcomes by addressing unmet medical needs with personalized and effective therapies.
Collaborative Ethos: Partnering with top-tier academic institutions, industry leaders, and medical researchers, we accelerate the journey from discovery to real-world application
Contact Us
Reach out to Immunova Biomed for inquiries about our innovative peptide-based nanomedicine solutions and collaborations.